Biomodulators in Cancer Treatment

作者: Malcolm S. Mitchell

DOI: 10.1002/J.1552-4604.1992.TB03779.X

关键词:

摘要:

参考文章(30)
JE Talmadge, M Schneider, J Keller, F Ruscetti, D Longo, R Pennington, O Bowersox, H Tribble, Myelostimulatory activity of recombinant human interleukin-2 in mice. Blood. ,vol. 73, pp. 1458- 1467 ,(1989) , 10.1182/BLOOD.V73.6.1458.1458
T A Hamilton, Z Steplewski, D O Adams, T J Matthews, H Koprowski, W J Johnson, Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation. Journal of Immunology. ,vol. 136, pp. 4704- 4713 ,(1986)
Robert K. Oldham, Biological Response Modifiers Journal of the National Cancer Institute. ,vol. 70, pp. 789- 796 ,(1983) , 10.1007/978-94-009-1095-9_1
JE Talmadge, H Tribble, R Pennington, O Bowersox, MA Schneider, P Castelli, PL Black, F Abe, Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors. Blood. ,vol. 73, pp. 2093- 2103 ,(1989) , 10.1182/BLOOD.V73.8.2093.2093
R Pennington, M Schneider, M P Castelli, J E Talmadge, P L Black, F Abe, Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. Journal of Immunology. ,vol. 140, pp. 3830- 3837 ,(1988)
R B Herberman, D A Cheresh, J R Ortaldo, R Reisfeld, C Woodhouse, A C Morgan, Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. Journal of Immunology. ,vol. 138, pp. 3566- 3572 ,(1987)
R M Hudziak, G D Lewis, M Winget, B M Fendly, H M Shepard, A Ullrich, p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Molecular and Cellular Biology. ,vol. 9, pp. 1165- 1172 ,(1989) , 10.1128/MCB.9.3.1165
PhilipO. Livingston, Gerd Ritter, MicheleJones Calves, Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse. Cancer Immunology, Immunotherapy. ,vol. 29, pp. 179- 184 ,(1989) , 10.1007/BF00199993
Steven A. Rosenberg, Michael T. Lotze, Linda M. Muul, Susan Leitman, Alfred E. Chang, Stephen E. Ettinghausen, Yvedt L. Matory, John M. Skibber, Eitan Shiloni, John T. Vetto, Claudia A. Seipp, Colleen Simpson, Cheryl M. Reichert, Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer The New England Journal of Medicine. ,vol. 313, pp. 1485- 1492 ,(1985) , 10.1056/NEJM198512053132327